AM

Archana Mahantesh Belle

Director Director DIN 07316283
DIN 07316283 First appointment Feb 2016 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Feb 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Archana Mahantesh Belle

Data last updated:

Archana Mahantesh Belle has 10 years in corporate governance. Formerly with 1 company, such as Maypharm Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07316283
Primary Designation Director
First Appointment 17 Feb 2016
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Feb 20162016₹15.79 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Maypharm Lifesciences Private Limited
Premium access

Shareholding and investment profile for Archana Mahantesh Belle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Archana Mahantesh Belle

Archana Mahantesh Belle has 10 years in corporate governance. Formerly with 1 company, such as Maypharm Lifesciences Private Limited. Engaged in General Business. Contributes to corporate operations.

Archana Mahantesh Belle has expertise in General Business.

Archana Mahantesh Belle has 10 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available